Medgenome
The status, timeline and source of this project. A free account opens every field.
Source: International Finance Corporation (IFC)
MedGenome Inc. (the “Company”), is a USA incorporated genetic diagnostics, research, and data licensing enterprise. It has a corporate office in Foster City, California. The Company established its Indian operations - MedGenome Laboratories Limited (MLL) - at Bengaluru in the year 2013; and is active in genomics and clinical data driven diagnostics and research with a focus on next generation sequ
- Status
- Prospective
- Sector
- Residential, Warehouse, Telecommunications, Commercial
- Location
- India
- Updated
- 22 Jul 2026
- Source
- International Finance Corporation (IFC)
ConstructChat
Ask ConstructChat about Medgenome
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | active |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | MedGenome Inc. (the “Company”), is a USA incorporated genetic diagnostics, research, and data licensing enterprise. It has a corporate office in Foster City, California. The Company established its Indian operations - MedGenome Laboratories Limited (MLL) - at Bengaluru in the year 2013; and is active in genomics and clinical data driven diagnostics and research with a focus on next generation sequencing (NGS).The Company had set-up a full-fledged genetics and diagnostics laboratory facility in Bengaluru, which offers genetic testing, genome sequencing, molecular diagnostics, and related services. The Company has set-up small satellite labs in other locations such as Mumbai, Cochin, Hyderabad etc. The diagnostic samples collected from customers/patients through its network of 1600+ hospitals and 5500+ clinicians in India are received at its lab facilities through third party commercial logistic service providers. The Company offers 475+ genetic tests across several disease categories such as paediatrics, neurology, oncology, haematology, endocrinology, nephrology, ophthalmology, etc. The proposed IFC investment in the Company involves preferred equity investment of up to US$16.5 million. IFC investment is to be deployed to build capacities and capabilities in: 1) developing diagnostics business unit (BU) operations such as: (i) geographic expansion to neighbouring countries around India (ii) screening and direct to consumer (DTC) test launch and (iv) small acquisitions and partnerships; and 2) developing Research and Data BU operations such as: (i) enriching SARGAM (South Asia Research Genotyping Array) Biobank; (ii) building informatics infrastructure; and (iii) enhancing disease specific deep data sets (the “Project”). |
Original sector | other |
Location
Country | India |
Source
Source | International Finance Corporation (IFC) |
URL |
More Details
Record type | Project |
Sector | Residential, Warehouse, Telecommunications, Commercial |
Article published date | 2026-04-26 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Residential projects in India
- Kiru Hydroelectric Project Jammu and Kashmir India
- Pinnapuram Integrated Renewable Energy Project India
- Construction of the Aga Hall Estate, a high-rise residential project (2 towers of 45 and 56 stories) in Mumbai (India)
- SEI Surya Lab Private Limited
- Salasar Highways Private Limited
- First Solar Telangana Power Plant
- Vijayawada Machiliapatnam Expressways Limited
- SB Energy Solar plant 350-MW
